[Federal Register: November 2, 2004 (Volume 69, Number 211)]
[Notices]
[Page 63541-63546]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr02no04-69]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Agency for Toxic Substances and Disease Registry
Public Health Conference Support Grant Program
Announcement Type: New.
Funding Opportunity Number: 05002.
Catalog of Federal Domestic Assistance Number: The Centers for
Disease Control and Prevention (CDC) Catalog of Federal Domestic
Assistance (CFDA) number is 93.283. The Agency for Toxic Substances and
Disease Registry (ATSDR) Catalog of Federal Domestic Assistance (CFDA)
number is 93.161.
DATES: Key Dates:
Letter of Intent (LOI) Deadline: Cycle A: November 24, 2004; Cycle
B: February 3, 2005.
Application Deadline: Cycle A: January 14, 2005; Cycle B: April 6,
2005.
I. Funding Opportunity Description
Authority: The Centers for Disease Control and Prevention (CDC)
program is authorized under section 317(k)(2) of the Public Health
Service Act, [42 U.S.C. 247b(k)(2)] as amended. The Agency for Toxic
Substances and Disease Registry (ATSDR) program is authorized under
sections 104 (i)(14) and (15) of the Comprehensive Environmental
Response, Compensation, and Liability Act of 1980 (CERCLA), as
amended by the Superfund Amendments and Reauthorization Act of 1986
(SARA), [42 U.S.C. 9604(i)(14) and (15)].
Purpose: The Centers for Disease Control and Prevention (CDC) and
the Agency for Toxic Substances and Disease Registry (ATSDR) announce
the pending availability of appropriated fiscal year (FY) 2005 funds
for a grant program for Public Health Conference Support. This program
addresses the ``Healthy People 2010'' focus areas of Disability and
Secondary Conditions, Educational and Community-Based Programs,
Environmental Health, Injury and Violence Prevention, Maternal, Infant
and Child Health, Vision and Newborn Hearing (specifically newborn
screening, evaluation and intervention), Public Health Infrastructure,
Tuberculosis, Respiratory Diseases, and Sexually Transmitted Diseases
(STD).
Human Immunodeficiency Virus (HIV) Conferences and HIV subject
matter are covered under another program and are not permitted under
this announcement.
The purpose of conference support funding is to provide partial
support for specific non-Federal conferences (not a series) in the
areas of health promotion and disease prevention information and
education programs, and applied research. A series is the exact same
conference conducted more than one time during the project period. An
applicant can apply for funding for more than one different conference
during the project period.
Congress has required that there will be active participation by
CDC/ATSDR in the development and approval of the conference agenda to
make sure there are no subjects that would embarrass the Government or
be an improper use of funds including portions that are not funded by
CDC/ATSDR. CDC/ATSDR funds will be expended only for approved portions
of the conference.
The mission of CDC is to promote health and improve the quality of
life by preventing and controlling disease, injury, and disability.
Through the support of conferences and meetings (not a series) in
the areas of public health research, education, prevention research in
program and policy development in managed care and prevention
application, CDC is meeting its overall goal of dissemination and
implementation of new cost-effective intervention strategies.
The mission of ATSDR is to prevent both exposure and adverse human
health effects that diminish the quality of life associated with
exposure to hazardous substances from waste sites, unplanned releases,
and other sources of pollution present in the environment.
ATSDR's systematic approaches are needed for linking applicable
resources in public health with individuals and organizations involved
in the practice of applying such research. Mechanisms are also needed
to shorten the time frame between the development of disease prevention
and health promotion techniques and their practical application. ATSDR
believes that conferences and similar meetings (not a series) that
permit individuals to engage in hazardous substances and environmental
health research, education, and application (related to actual and/or
potential human exposure to toxic substances) to interact, are critical
for the development and implementation of effective programs to prevent
adverse health effects from hazardous substances.
Measurable outcomes of the program will be in alignment with one
(or more) of the following performance goal(s):
Agency for Toxic Substances and Disease Registry (ATSDR):
Prevent ongoing and future exposures and resultant health
effects from hazardous waste sites and releases;
[[Page 63542]]
Determine human health effects associated with exposures
to superfund-related priority hazardous substances;
Mitigate the risks of human effects at toxic waste sites
with documented exposures;
Build and enhance effective partnerships;
Promote effective and efficient agency management.
National Center of Birth Defects and Developmental Disabilities
(NCBDDD):
Increase the consumption of folic acid among women of
reproductive age to prevent serious birth defects;
Decrease the number of women drinking during pregnancy;
Monitoring speech, language, and other developmental
outcomes of infants with hearing loss;
Improve the data on the prevalence of birth defects and
developmental disabilities;
Find causes and risk factors for birth defects and
developmental disabilities in order to develop prevention strategies;
Monitor, characterize, and improve the health status of
Americans with disabilities;
Increase knowledge by developing and implementing
evidence-based approaches on adverse consequences of hereditary
conditions including blood disorders.
National Center for Environmental Health Services (NCEH):
Determine Human Health effects associated with
environmental exposures and hazards;
Ensure laboratory standards are maintained in all
certified labs for the following tests associated with health effects:
Lipids, Newborn Screening, Blood Lead, and Urinary Iodine;
Ensure that 100 percent of chemical stockpiles housed at
federal facilities are disposed of without any serious injuries or
deaths from chemical agents;
Build and enhance effectively partnerships to improve
environmental health capacity;
Provide assistance to 20 partners;
Promote effective and efficient NCEH management.
National Center for (HIV), STD, and Tuberculosis (TB) Prevention
(NCHSTP):
Strengthen the capacity of our STD, TB, and HIV prevention
partners nationwide to monitor STD, TB, and HIV epidemic;
Develop and implement effective STD, TB, and HIV
prevention interventions, and evaluate prevention programs.
National Center for Injury Prevention and Control (NCIPC):
Reduce the risk of youth violence;
Reduce violence against women;
Enhance the capacity of states to implement effective rape
prevention and education programs;
Reduce the number and severity of head injuries by
increasing bicycle helmet use;
Improve the timelines and quality of data used to
determine the medical and social impact of traumatic brain injury;
Reduce the incidence of residential fire-related injuries
and deaths by increasing functional smoke alarms on every habitable
floor;
Increase external input on the research priorities,
policies, and procedures related to the extramural research supported
by CDC;
Provide online access to injury prevention data;
Improve the uniformity, quality, and accessibility of
emergency department data for public health surveillance in several
states; ultimately developing the capacity to improve data in all
states through development of guidelines, recommendations, or technical
assistance.
Public Health Practice Program Office (PHPPO):
Continue efforts to protect the safety and security of
laboratorians regarding the handling and processing of biological
agents;
Enhance the capacity (including laboratory) of CDC and
state and local health departments to prepare for and respond to a
biological and chemical terrorism event through rapid and accurate
detection means, including the investigation and communication of
critical information;
Continue efforts to protect the health and safety of first
responders during biological and chemical terrorism events.
Implement training programs to provide an effective
workforce for U.S. health departments and laboratories and ministries
of health in developing countries;
Ensure state and local health departments will monitor the
health of its communities, and assist in the detection of emerging
public health problems;
Conduct research to identify and evaluate community-based
prevention interventions;
Strengthen the ability to obtain and disseminate
extramural research findings to partners, public health practitioners,
managed care organizations, and the public through a prevention
research communications program;
Increase input from the external scientific community on
extramural prevention research and strengthen the scope and nature of
extramural public health research programs;
Disseminate research findings and other relevant
information from prevention research programs to public health
practitioners, managed-care organizations, and consumer groups;
Increase collaborations focusing on innovative
intervention methods.
This announcement is only for non-research activities supported by
CDC/ATSDR. If research is proposed, the application will not be
reviewed. For the definition of research, please see the CDC Web site
at the following Internet address: http://www.cdc.gov/od/ads/opspoll1.htm
.
Activities: In conducting activities to achieve the purpose of this
program, the recipient will be responsible for the following
activities:
The conference organizer(s) may use CDC's/ATSDR's name
only in factual publicity for the conference. CDC/ATSDR involvement in
the conference does not necessarily indicate support for the
organizer's general policies, activities, products, or the content of
speakers' presentations.
Any national conference co-sponsored under this
announcement shall be held in facilities that are fully accessible to
the public as required by the Americans with Disabilities Act
Accessibility Guidelines (ADAAG)(Does not apply to international
conferences). Accessibility under ADAAG addresses accommodations for
persons with sensory impairments as well as persons with physical
disabilities or mobility limitations.
Manage all activities related to program content (e.g.,
objectives, topics, attendees, session design, workshops, special
exhibits, speaker's fees, agenda composition, and printing). Many of
these items may be developed in concert with assigned CDC or ATSDR
project personnel.
Provide draft copies of the agenda and proposed ancillary
activities to CDC or ATSDR for approval. All but ten percent of the
total funds awarded for the proposed conference will be initially
restricted pending approval of a full, final agenda by CDC or ATSDR.
The remaining 90 percent of funds will be released by letter to the
grantee upon the approval of the final agenda. Because conference
support by CDC and ATSDR creates the appearance of CDC co-sponsorship,
there will be active participation by CDC or ATSDR in the development
and approval of those portions of the agenda supported by CDC funds.
CDC funds will not be expended for non-approved portions of meetings.
In addition, CDC will reserve
[[Page 63543]]
the right to approve or reject the content of the full agenda, press
events, promotional materials (including press releases), speaker
selection, and site selection. CDC and ATSDR reserve the right to
terminate co-sponsorship if it does not concur with the final agenda.
Determine and manage all promotional activities (e.g.,
title, logo, announcements, mailers, press, etc.). CDC or ATSDR must
review and approve any materials with reference to CDC or ATSDR
involvement or support.
Manage all registration processes with participants,
invitees, and registrants (e.g., travel, reservations, correspondence,
conference materials and handouts, badges, registration procedures,
etc.).
Plan, negotiate, and manage conference site arrangements,
including all audio-visual needs.
II. Award Information
Type of Award: Grant.
Fiscal Year Funds: FY 2005.
Approximate Total Funding: Approximately $600,000 may be available
from CDC in FY 2005 to fund approximately 30 to 55 awards.
Approximately $25,000 is available from ATSDR in FY 2005 to fund
approximately three to five awards.
Approximate Number of Awards: 60.
Approximate Average of Awards: It is expected that the average
award will be $20,000 for CDC and $8,000 for ATSDR.
Floor of Award Range: None.
Ceiling of Award Range: None.
Anticipated Award Date: On or about sixty days before the date of
the conference.
Budget Period Length: 12 month budget period for each cycle.
Project Period Length: 12 month project period for each cycle.
III. Eligibility Information
III.1. Eligible Applicants
Applications may be submitted for CDC support by public and private
nonprofit organizations and by governments and their bona fide
agencies, such as:
Public nonprofit organizations.
Private nonprofit organizations.
Faith-Based organizations.
Universities and Colleges.
Voluntary associations.
Foundations and civic groups.
Scientific or professional associations.
Federally recognized Indian tribal governments.
Applications for ATSDR support in addition to the above may be
submitted by the official public health agencies of the States or their
bona fide agents. This includes:
The District of Columbia, the Commonwealth of Puerto Rico,
the Virgin Islands, the Commonwealth of the Northern Marianna Islands,
American Samoa, Guam, the Federated States of Micronesia, the Republic
of the Marshall Islands, and the Republic of Palau.
Political subdivisions of States (in consultation with
States).
A bona fide agent is an agency/organization identified by the state
as eligible to submit an application under the state eligibility in
lieu of a state application. If you are applying as a bona fide agent
of a state or local government, you must provide a letter from the
state or local government as documentation of your status. Place this
documentation behind the first page of your application form.
Also eligible are nationally and internationally recognized
associations of health professionals and other chartered organizations
generally recognized as demonstrating a need for information to protect
the public from health effects of exposure to hazardous substances.
Only conferences planned for May 1, 2005 through September 30, 2006
are eligible to apply under this announcement.
III.2 Cost Sharing or Matching
Matching funds are not required for this program.
III.3 Other
CDC will accept and review applications with budgets greater than
the ceiling of the award range. No ceiling limit has been established
for Conference Support budgets. Refer to II Award Information for award
ranges.
Special Requirements
Late applications will be considered non-responsive. See
section ``IV.3. Submission Dates and Times'' for more information on
deadlines.
Applicants who do not submit a LOI will not be eligible to
submit an application for review or funding.
Note: Title 2 of the United States Code Section 1611
states that an organization described in Section 501(c)(4) of the
Internal Revenue Code that engages in lobbying activities is not
eligible to receive Federal funds constituting an award, grant, or
loan.
IV. Application and Submission Information
IV.1. To Request Application Package
To apply for this funding opportunity use application form PHS
5161-1 (OMB Number 0937-0189). Application forms and instructions are
available on the CDC Web site, at the following Internet address:
http://www.cdc.gov/od/pgo/forminfo.htm.
If you do not have access to the Internet, or if you have
difficulty accessing the forms on-line, you may contact the CDC
Procurement and Grants Office Technical Information Management Section
(PGO-TIM) staff at: 770-488-2700. Application forms can be mailed to
you.
IV.2. Content and Form of Submission
Letter of Intent (LOI):
A Letter of Intent is required for this Program Announcement. The
LOI will not be evaluated or scored. Your LOI will be used to estimate
the potential reviewer workload and to avoid conflicts of interest
during the review. You must submit an original and two copies. If you
do not submit a LOI, you will not be allowed to submit an application.
Your LOI must be written in the following format:
Maximum number of pages: two to three typewritten pages.
Font size: 12-point unreduced.
Single spaced.
Paper size: 8.5 by 11 inches.
Page margin size: One inch.
Printed only on one side of page.
Written in plain language, avoid jargon.
Your LOI must contain the following information:
The name of the organization.
Primary contact person's name.
Mailing address.
Telephone number and, if available, fax and e-mail.
Title of the proposed conference-include the term
``conference,'' ``symposium,'' or similar designation.
Date(s) of conference-inclusive dates (not a series) of
the conference. A series would be the exact same conference conducted
more than one time.
Location of city, state, and physical facilities required
for the conduct of the meeting.
Main Conference topics (no more than 2). See attachment
II.
Total conference cost and total requested from CDC (must
be less than 100 percent).
Intended audience, approximate number, and profession of
persons expected to attend.
Justification for the conference.
This information must also be included in a summary page sent with
the application.
Application: You must submit a project narrative with your
application forms. The narrative must be submitted in the following
format:
[[Page 63544]]
Maximum number of pages: 12 pages. If your narrative
exceeds the page limit, only the first pages, which are within the page
limit, will be reviewed.
Font size: 12 point unreduced.
Double spaced.
Paper size: 8.5 by 11 inches.
Page margin size: One inch.
Printed only on one side of page.
Clearly numbered pages.
A complete index to the application and appendices.
Held together only by rubber bands or metal clips; not
bound in any other way.
Your narrative should address activities to be conducted during the
entire project period:
A brief background of the organization--include the
organizational history, purpose, and previous experience related to the
proposed conference topic.
A clear statement of the need for and purpose of the
conference. This statement should also describe any problems the
conference will address or seek to solve, and the action items or
resolutions it may stimulate.
An elaboration on the conference objectives and target
audience. A list should be included of the principal areas or topics to
be addressed. A proposed or final agenda must be included.
A clear description of the evaluation plan and how it will
assess the accomplishments of the conference objectives. A sample of
the evaluation instrument that will be used must be included and a
step-by-step schedule and detailed operation plan of major conference
planning activities necessary to attain specified objectives.
Budget plan and justification--A clearly justified budget
narrative that is consistent with the purpose, objectives, and
operation plan of the conference. It should include the share requested
from this grant as well as those funds from other sources, including
organizations, institutions, conference income, and/or registration
fees. (The 12 page limit does not include the budget.)
Additional information may be included in the application
appendices. The appendices will not be counted toward the narrative
page limit. This additional information includes:
Biographical sketches are required for the individuals
responsible for planning and implementing the conference. Experience
and training related to conference planning and implementation as it
relates to the proposed topic should be noted.
Letters of endorsement or support--Letters of endorsement
or support for the sponsoring organization and its capability to
perform the proposed conference activity.
You are required to have a Dun and Bradstreet Data Universal
Numbering System (DUNS) number to apply for a grant or cooperative
agreement from the Federal government. The DUNS number is a nine-digit
identification number, which uniquely identifies business entities.
Obtaining a DUNS number is easy and there is no charge. To obtain a
DUNS number, access http://www.dunandbradstreet.com or call 1-866-705-5711.
For more information, see the CDC Web site at: http://www.cdc.gov/od/pgo/funding/pubcommt.htm
.
Please include your DUNS number in your application cover letter.
IV.3. Submission Dates and Times
Deadline:
LOI and application deadlines have now been imposed for all
conference support grants, and dates should be strictly followed by
applicants to ensure that their LOIs and applications are received in a
timely manner. There will be two conference support reviews this year.
If your conference dates fall between May 1, 2005, to April 30, 2006,
you should apply under Cycle A under this announcement.
If your conference dates fall between August 1, 2005, to September
30, 2006, you should apply under Cycle B under this announcement.
Letter of Intent Due Dates:
Cycle A: November 24, 2004.
For conferences May 1, 2005-April 30, 2006.
Cycle B: February 3, 2005.
For conferences August 1, 2005-September 30, 2006.
Letter of Intent (LOI) Submission:
On or before November 24, 2004, and February 3, 2005, submit an
original and two signed copies of the LOI to: Technical Information
Management PA05002, Procurement and Grants Office, Centers for
Disease Control and Prevention, 2920 Brandywine Road, Atlanta, GA
30341-4146.
Applicants who do not submit an LOI will not be eligible to submit
an application for review or funding.
Application Due Dates: Earliest Possible Award Dates:CYCLE A:
January 14, 2005, April 2005. CYCLE B: April 6, 2005, June 2005.
Submit application to:
Technical Information Management PA05002, Procurement and
Grants Office, Centers for Disease Control and Prevention, 2920
Brandywine Road, Atlanta, GA 30341-4146.
Applications may not be submitted electronically. Applications
received that were not preceded by a LOI will not be reviewed or
funded.
Explanation of Deadlines: LOIs and Applications must be received in
the CDC Procurement and Grants Office by 4 p.m. Eastern Time on the
deadline date. If you submit your LOI or application by the United
States Postal Service or commercial delivery service, you must ensure
that the carrier will be able to guarantee delivery by the closing date
and time. If CDC receives your submission after closing due to: (1)
Carrier error, when the carrier accepted the package with a guarantee
for delivery by the closing date and time, or (2) significant weather
delays or natural disasters, you will be given the opportunity to
submit documentation of the carriers guarantee. If the documentation
verifies a carrier problem, CDC will consider the submission as having
been received by the deadline.
This announcement is the definitive guide on LOI and application
content, submission address, and deadline. It supersedes information
provided in the application instructions. If your submission does not
meet the deadline above, it will not be eligible for review, and will
be discarded. You will be notified that you did not meet the submission
requirements.
CDC will not notify you upon receipt of your submission. If you
have a question about the receipt of your LOI or application, first
contact your courier. If you still have a question, contact the PGO-TIM
staff at: 770-488-2700. Before calling, please wait two to three days
after the submission deadline. This will allow time for submissions to
be processed and logged.
IV.4. Intergovernmental Review of Applications
Your application is subject to Intergovernmental Review of Federal
Programs, as governed by Executive Order (EO) 12372. This order sets up
a system for state and local governmental review of proposed federal
assistance applications. You should contact your state single point of
contact (SPOC) as early as possible to alert the SPOC to prospective
applications, and to receive instructions on your state's process.
Click on the following link to get the current SPOC list: http://www.whitehouse.gov/omb/grants/spoc.html
.
IV.5. Funding Restrictions
Restrictions, which must be taken into account while writing your
budget, are as follows:
Funds may be used for direct cost expenditures: Salaries;
speaker fees (for
[[Page 63545]]
services rendered); rental of necessary conference--related equipment;
registration fees; and transportation costs (not to exceed economy
class fare) for non-Federal individuals.
Funds may be used for only those parts of the conference
specifically supported by CDC or ATSDR as documented in the grant
award.
Funds may not be used for the purchase of equipment;
payments of honoraria (different from speaker fees in that it would be
for someone to draw attention to the conference such as a celebrity and
who usually has no expertise in the public health area); alterations or
renovations; organizational dues; support entertainment or personal
expenses; food or snack breaks; cost of travel and payment of a Federal
employee or per diem or expenses for local participants (other than
local mileage). Travel for Federal employees will be supported by CDC/
ATSDR. Travel for other Federal employees will be supported by the
employees' Federal agency.
Funds may not be used for reimbursement of indirect costs.
CDC and ATSDR will not fund 100 percent of any conference
proposed under this announcement. Part of the cost of the proposed
conference must be supported with funds other than Federal funds.
CDC and ATSDR will not fund a conference after it has
taken place.
Federal funds may not be used to fund novelty items or
souvenirs.
Guidance for completing your budget can be found on the CDC Web
site, at the following Internet address: http://www.cdc.gov/od/pgo/funding/budgetguide.htm
.
IV.6. Other Submission Requirements
LOI and Application Submission Address: Submit your original and
two hard copies of LOI and application by express mail or delivery
service to: Technical Information Management Section, PA 05002,
Procurement and Grants Office, Centers for Disease Control and
Prevention, 2920 Brandywine Road, Room 3000, Atlanta, Georgia 30341-
4146. LOIs and applications may not be submitted electronically at this
time.
V. Application Review Information
V.1. Criteria
Applicants are required to provide measures of effectiveness that
will demonstrate the accomplishment of the various identified
objectives of the grant. Measures of effectiveness must relate to the
performance goals stated in the ``Purpose'' section of this
announcement. Measures must be objective and quantitative, and must
measure the intended outcome. These measures of effectiveness must be
submitted with the application and will be an element of evaluation.
Each application will be evaluated individually against the
following criteria by an independent review group appointed by CDC.
Section 1.a., is ATSDR specific
Section 1.b., is CDC specific
Section 1.c., and all other sections in these criteria are applicable
to both CDC and ATSDR. Each application will be evaluated based on the
following criteria:
1. Proposed Program and Technical Approach (25 Points)
a. The public health significance of the proposed conference,
including the degree to which the conference can be expected to
influence the prevention of exposure and adverse human health effects
and diminished quality of life associated with exposure to hazardous
substances from waste sites, unplanned releases and other sources of
pollution present in the environment (Applicable to ATSDR applications
only).
b. The applicant's description of the proposed conference as it
relates to specific non-Federal conferences in the areas of health
promotion and disease prevention information/education programs (except
substance abuse), including the public health need of the proposed
conference and the degree to which the conference can be expected to
influence public health practices. Evaluation will also be based on the
extent of the applicant's collaboration with other organizations
serving the intended audience (Applicable to all CDC applications
except ATSDR).
c. The applicant's description of conference objectives in terms of
quality, specificity, and the feasibility of the conference based on
the operational plan will also be evaluated.
2. Conference Objectives (25 Points)
a. The overall quality, reasonableness, feasibility, and logic of
the designed conference objectives, including the overall work plan and
timetable are accomplished.
b. The likelihood of accomplishing conference objectives as they
relate to disease prevention and health promotion goals, and the
feasibility of the project in terms of the operational plan.
3. The Qualifications of Program Personnel (20 Points)
Evaluation will be based on the extent to which the application has
described:
a. The extent to which the application provides evidence of the
qualifications, experience, and commitment of the principal staff
person, and his/her ability to devote adequate time and effort to
provide effective leadership.
b. The extent to which the application provides evidence of the
competence of associate staff persons, discussion leaders, speakers,
and presenters to accomplish conference objectives.
c. The extent to which the application demonstrates the knowledge
of nationwide and educational efforts currently underway which may
affect, and be affected by, the proposed conference.
4. Evaluation Methods (20 Points)
Evaluation instrument(s) for the conference should adequately
assess increased knowledge, attitudes, and behaviors of the target
audience.
5. Applicant's Capability (10 Points)
a. The applicant's capability includes the adequacy of the
applicant's resources (additional sources of funding, organization's
strengths, staff time, proposed physical facilities, etc.) available
for conducting conference activities.
b. The extent to which the applicant demonstrates a history (at
least three years) of managing conferences.
6. Budget Justification and Adequacy of Facilities (Not Scored)
The proposed budget will be evaluated on the basis of its
reasonableness, concise and clear justification, and consistent with
the intended use of grant funds. The application will also be reviewed
as to the adequacy of existing or proposed facilities and resources for
conducting conference activities.
V.2. Review and Selection Process
Applications will be reviewed for completeness by the Procurement
and Grants Office (PGO) staff, and for responsiveness by the relevant
CIO. Incomplete applications and applications that are non-responsive
to the eligibility criteria will not advance through the review
process. Applicants will be notified that their application did not
meet submission requirements.
An objective review panel consisting of CDC members outside the
funding center will evaluate complete and responsive applications
according to the criteria listed in the ``V.1. Criteria'' section
above. Three reviewers from CDC staff that are not employees of the
cognizant center will review and present their findings to the panel.
The panel votes to approve or disapprove
[[Page 63546]]
based on this information and each application is scored and ranked.
In addition, the following factors may affect the funding decision:
Availability of funds
Relevance to program priorities.
Applications will be funded in order by score and rank determined
by the review panel. CDC/ATSDR will provide justification for any
decision to fund out of rank order.
V.3. Anticipated Announcement and Award Dates
The anticipated announcement date is November 1, 2004 and the award
dates will be 30-60 days before the conferences begin.
VI. Award Administration Information
VI.1. Award Notices
Successful applicants will receive a Notice of Grant Award (NGA)
from the CDC Procurement and Grants Office. The NGA shall be the only
binding, authorizing document between the recipient and CDC. The NGA
will be signed by an authorized Grants Management Officer, and mailed
to the recipient fiscal officer identified in the application.
Unsuccessful applicants will receive notification of the results of
the application review by mail.
VI.2. Administrative and National Policy Requirements
45 CFR part 74 and part 92.
For more information on the Code of Federal Regulations, see the
National Archives and Records Administration at the following Internet
address: http://www.access.gpo.gov/nara/cfr/cfr-table-search.html.
The following additional requirements apply to this project:
AR-7 Executive Order 12372.
AR-9 Paperwork Reduction Act Requirements.
AR-10 Smoke-Free Workplace Requirements.
AR-11 Healthy People 2010.
AR-12 Lobbying Restrictions.
AR-13 Prohibition on Use of CDC Funds for Certain Gun
Control Activities.
AR-15 Proof of Non-Profit Status.
AR-20 Conference Support.
Additional information on these requirements can be found on the
CDC Web site at the following Internet address: http://www.cdc.gov/od/pgo/funding/ARs.htm
.
VI.3. Reporting Requirements
You must provide CDC with an original, plus two hard copies of the
following reports:
1. Interim progress report, due no less than 90 days before the end
of the budget period.
2. Financial status report, due no later than 90 days after the end
of the budget period/project.
These reports must be mailed to the Grants Management or Contract
Specialist listed in the ``Agency Contacts'' section of this
announcement.
VII. Agency Contacts
We encourage inquiries concerning this announcement.
For general questions, contact: Technical Information Management
Section, CDC Procurement and Grants Office, 2920 Brandywine Road,
Atlanta, GA 30341, telephone: 770-488-2700.
For program technical assistance, contact: Refer to the Attachment
for contacts listed per each center.
For business management assistance, contact: Edna Green, Grants
Management Specialist, CDC Procurement and Grants Office, 2920
Brandywine Road, Atlanta, GA 30341, telephone: 770-488-2743. e-mail:
egreen@cdc.gov.
VIII. Other Information
This and other CDC funding opportunity announcements can be found
on the CDC Web site, Internet address: http://www.cdc.gov. Click on
``Funding'' then ``Grants and Cooperative Agreements.''
Dated: October 27, 2004.
William P. Nichols,
Acting Director, Procurement and Grants Office, Centers for Disease
Control and Prevention.
Attachment
Topic Areas of Programmatic Interest and Contact Information
100. Agency for Toxic Substances and Disease Registry (ATSDR)--
LaShonda Billingsley, (404) 498-0275, LBillingsley@cdc.gov.
100.1 Health effects of hazardous substances in the environment;
100.2 Disease and toxic substance exposure registries;
100.3 Hazardous substance removal and remediation;
100.4 Emergency Response to toxic and environmental disasters;
100.5 Risk communication;
100.6 Environmental Disease Surveillance;
100.7 Investigation and research on hazardous substances in the
environment
300. National Center on Birth Defects and Developmental Disabilities
(NCBDDD)--Sheryl Heard, (404) 498-3978, SHeard@cdc.gov.
300.1 Birth Defects
300.2 Fetal Alcohol Syndrome
300.3 Disabilities: Issues related to people with disabilities;
health promotion and intervention for persons with disabilities;
secondary conditions; and aging and disability;
300.4 Newborn and Childhood screening: Hearing, metabolic, genetic,
and developmental
300.5 Hearing Loss, early interventions, genetic causes
300.6 Mental Retardation
300.7 Child Development
300.8 Autism Spectrum Disorders and Other Developmental Disabilities
300.9 Hereditary Blood Disorders
500. National Center for Environmental Health (NCEH)--LaShona
Billingsley, (404) 498-0275, LBillingsley@cdc.gov.
500.1 Genetics and Disease Prevention
500.2 Emergency and Environmental Health Services (lead poisoning,
environmental health hazards)
500.3 Environmental Hazards and Health Effects (air pollution,
asthma, health studies)
500.4 Division of Laboratory Sciences (air toxins, newborn
screening)
600. National Center HIV, STD, and TB Prevention (NCHSTP)--Beth
Wolfe, (404) 639-8531, BWolfe@cdc.gov.
600.1 Sexually Transmitted Diseases (not HIV)
600.2 Tuberculosis in Foreign Born Persons in the United States
600.3 Tuberculosis in African American Populations in the United
States (especially in the Southeast)
600.4 Therapeutics and Diagnostics
800.0 National Center for Injury Prevention and Control (NCIPC)--
Benjamin Moore, (770) 488-4710, Moore@cdc.gov.
800.1 Unintentional Injuries Prevention
800.2.1 National level conferences that focus on preventing child
maltreatment before it occurs (primary prevention)
800.2.2 National level conferences that focus on preventing youth
violence before it occurs (primary prevention)
800.3 Acute Injury Care
800.4 Traumatic Brain Injury (TBI)
800.5 Injury Related Disability
800.6 Preparedness and Response for Injuries Resulting from Mass
Causality Events and/or Terrorist Attacks
800.7 Impact Biomechanics
1500. Public Health Practice Program Office (PHPPO)--Janet Telman,
(770) 488-2834, JTelman@cdc.gov.
1500.1 Laboratory Practice
1500.2 Training and Materials
[FR Doc. 04-24390 Filed 11-1-04; 8:45 am]
BILLING CODE 4163-18-P